Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

World’s Most Precise Nanolitre Microplate Dispenser on Show at SLAS2013

Published: Tuesday, January 08, 2013
Last Updated: Tuesday, January 08, 2013
Bookmark and Share
Redd&Whyte Preddator system on booth #231 achieves validated CVs of less than 1%.

Redd&Whyte announced it is showing its Preddator liquid handling system for dispensing even difficult to pipette liquids into microplates on Booth #231 at the Society for Laboratory Automation and Screening (SLAS) 2013 Conference in Orlando, USA. The system, which features unique dispense head technology, achieves less than 1 % CVs at nanolitre volumes, ensuring scientists can save time and reagent costs by generating consistent low-volume microplate assay results time after time.

nL-microplate.gifThe Preddator system on show at SLAS2013 recently underwent rigorous independent microplate dispensing performance checks with the National Institute of Standards and Technology (NIST) approved Artel MVS® multichannel verification system. These tests showed that Preddator can achieve an accuracy of 0.69% CVs at 500 nl, across 384-well plates, which ensures researchers can use Preddator to reduce assay reagent volumes with confidence and potentially cut the expense of each assay to deliver substantial cost savings in for example, high throughput screening programmes.


The Preddator on Booth #231 is also the only automated commercial nanolitre microplate dispenser that can reliably pipette difficult to dispense substances such as DMSO, oils, detergents and  gels, as well as cells, proteins and other biological samples. On the booth, Redd&Whyte’s experts will explain how Preddator’s unique dispense head is designed with a solenoid to work continuously, saving scientists time as they can leave Preddator unattended when dispensing viscous reagents or cells, without worrying about blockages and inaccurate assay data which can result from inconsistent dispensing.

Roger Poole, Managing Director of Redd&Whyte commented: “We’re delighted to be showcasing our Preddator system at SLAS2013. This dispenser has been developed with scientists at two major pharma companies over two years so now to be delivering unrivalled percentage CVs that are between 5-10 fold better than any other low-volume microplate dispenser commercially available is an excellent achievement.”

Poole added: “We look forward to meeting researchers on Booth #231 that need robust and reproducible low-volume dispensing performance with even difficult viscous liquids and to discussing how using Preddator will help them significantly reduce their reagent costs, while increasing productivity and the quality of data from their assay screening programmes.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Preddator Low-volume Microplate Dispenser Awarded ELRIG Prize
Recognizing technology’s novel method of improving liquid handling efficiency.
Wednesday, July 10, 2013
Redd&Whyte Appoints HighRes Biosolutions as New US Distributor
Appointment offers US scientists specialist access to its unique liquid handling technology.
Thursday, February 28, 2013
Redd&Whyte Appoints New UK Sales Manager
Appointment to provide professional service and support for UK scientists.
Thursday, February 21, 2013
Redd&Whyte Appoints New Director of Business Development
Appointment of Rob Harkness as part of new growth strategy.
Thursday, August 23, 2012
Redd&Whyte wins Best New Company at the Life Science Awards
Redd&Whyte was awarded Best New Company at the inaugural Life Science Awards, on 29 June in Hamburg, Germany, preceding the first European Lab Automation conference and exhibition.
Thursday, July 07, 2011
Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!